System for predicting prognosis and benefit from adjuvant chemotherapy for patients with stage II and III gastric cancer

摘要

The present invention relates to a postoperative prognostic or anticancer drug predictive system for patients with advanced gastric cancer, and to predict prognostic and anticancer drug suitability using the quantitative test results of the mRNA expression levels of the prognostic or anticancer drug marker gene group and the reference gene group of advanced gastric cancer patients. The algorithm can be used as an aid in determining the treatment of gastric cancer patients.